Integrated Smoking Cessation Treatment for Low Income Community Corrections
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 19 - 80 |
| Updated: | 4/19/2017 |
| Start Date: | October 2009 |
| End Date: | March 2014 |
This study recruited cigarette smokers under supervision in community corrections (e.g.,
probation, parole, drug courts, etc.) in the Birmingham, Alabama area. Smokers received 12
weeks of bupropion treatment and brief physician advice to quit smoking or 12 weeks of
bupropion treatment and 4 sessions of intensive counseling around smoking cessation. The
study was stratified on race such that equal proportions of African Americans and Caucasians
were enrolled in the two study groups. It was hypothesized that smokers receiving intensive
counseling will have higher quit rates compared to smokers receiving brief advice to quit.
probation, parole, drug courts, etc.) in the Birmingham, Alabama area. Smokers received 12
weeks of bupropion treatment and brief physician advice to quit smoking or 12 weeks of
bupropion treatment and 4 sessions of intensive counseling around smoking cessation. The
study was stratified on race such that equal proportions of African Americans and Caucasians
were enrolled in the two study groups. It was hypothesized that smokers receiving intensive
counseling will have higher quit rates compared to smokers receiving brief advice to quit.
Inclusion Criteria:
- At least 19 years or older
- Enrolled in criminal justice community supervision (e.g., probation, parole, drug
court, community corrections, etc)
- Smoking at least 5 cpd for the past year
- Maintained in an unrestricted environment (e.g., not currently in a correctional
facility or treatment facility) living in the Birmingham Area and surrounding
communities
Exclusion Criteria:
- Pregnant or nursing (all women in this study will be required to use an acceptable
form of contraception throughout the administration of the medication)
- Known sensitivity to Zyban or Wellbutrin
- History of seizures
- Current or prior anorexia or bulimia
- Abrupt withdrawal from alcohol or benzodiazepines
- Moderate to severe kidney problems
- Moderate liver problems
- Cognitive impairment such that they cannot provide informed consent
We found this trial at
1
site
Click here to add this to my saved trials
